Schimmelt 2
Eindhoven NL-5656
Netherlands
https://www.onwd.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 99
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. David L. Marver | CEO & Executive Director | 767k | N/A | 1968 |
Dr. Gregoire Courtine Ph.D. | Chief Scientific Officer & Director | N/A | N/A | 1975 |
Mr. Khaled Bahi | Interim Chief Financial Officer | N/A | N/A | 1966 |
Mr. Robert W. Odell | Vice President of Operations | N/A | N/A | 1960 |
Mr. John Murphy | Chief Technology Officer | N/A | N/A | N/A |
Ms. Sarah Moore | Vice President of Global Marketing | N/A | N/A | N/A |
Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Onward Medical N.V.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.